MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale or
maturities of marketable...
$83,326K
Proceeds from exercise of
common stock
$3,854K
Net cash provided by
investing activities
$38,429K
Net cash provided by
(used in) financing...
$3,365K
Canceled cashflow
$44,897K
Canceled cashflow
$489K
Net change in cash,
cash equivalents and...
$24,525K
Canceled cashflow
$17,269K
Purchases of marketable
securities
$44,815K
Purchase of property and
equipment
$82K
Share-based compensation
$5,073K
Rou asset
amortization
$353K
Depreciation and
amortization
$15K
Taxes paid related to
net shares...
$489K
Net cash used in
operating activities
-$17,269K
Canceled cashflow
$5,441K
Net loss
-$18,317K
Accrued expenses
-$3,383K
Accounts payable
-$679K
Amortization of premium and
discount on marketable...
-$206K
Prepaid expenses and
other current assets
$87K
Operating lease liability
-$38K
Back
Back
Cash Flow
Compass Therapeutics, Inc. (CMPX)
Compass Therapeutics, Inc. (CMPX)
source: myfinsight.com